Ohara Pharmaceutical Co., Ltd.

Japon

Commandez votre montre hebdomadaire Ohara Pharmaceutical Co., Ltd.
Quantité totale PI 37
Rang # Quantité totale PI 39 255
Note d'activité PI 2,2/5.0    19
Rang # Activité PI 43 249

Brevets

Marques

9 0
0 0
28 0
0
 
Dernier brevet 2025 - Pharmaceutical composition for o...
Premier brevet 2003 - Heterocyclic compound and antitu...

Derniers inventions, produits et services

2024 Invention Pharmaceutical composition for oral administration of dnmt inhibitor. The present disclosure prov...
2023 Invention Levodopa sustained release formulation. The present disclosure provides an oral pharmaceutical co...
Invention Liver fibrosis therapeutic regimen for cbp/catenin inhibitor. [Problem] To provide a pharmaceutic...
Invention Modified sirna for selectively inhibiting expression of mutant fus. [Problems] [Problems] To p...
Invention Modified sirna for selectively inhibiting expression of mutant fus. [Problem] To provide a chemic...
2022 Invention Inhibitor for chronic myeloid leukemia stem cells. The present invention relates to an inhibitor...
Invention Inhibitor for chronic myeloid leukemia stem cells. The present invention provides an inhibitor fo...
2021 Invention Stroke diagnosis and therapy assistance system, stroke state information providing device, and st...
Invention Sirna and use thereof. The present invention provides siRNA which selectively exhibits silencing...
Invention Sirna and use thereof. The present invention provides: an siRNA that selectively suppresses the e...
Invention Method for diagnosing and treating blood cancer. The present invention provides: a method for id...
Invention Method for diagnosing and treating blood cancer. The present invention provides: a method for ide...
2020 Invention Use of dnmt inhibitor. [Problems] The object is to provide a compound as a therapeutic or prophyl...
Invention Use of dnmt inhibitor. [Problem] As a substitute for an injection "Dacogen (registered trademark)...
Invention Disease diagnosis/treatment support system. [Problem] To provide a stroke diagnosis/treatment sup...
Invention Adult t-cell leukemia-lymphoma detection method. An adult T-cell leukemia-lymphoma (ATL) detectio...
2019 Invention Pharmaceutical composition. Provided, as a cancer prophylactic drug or a cancer therapeutic drug,...
Invention Disease diagnosis/treatment assistance system. [Problem] To provide a stroke diagnosis/treatment ...
Invention Use of dnmt inhibitor. [Problem] To provide, as a therapeutic or prophylactic agent for ATL, a co...
Invention Method for improving chemical stability of γ-aminobutyric acid derivative- containing tablet. Thi...
2018 Invention Method for improving chemical stability of pregabalin by particle size control. A method for prod...
Invention Amorphous-solifenacin drug package. The present invention stabilizes either amorphous solifenacin...
Invention Orally disintegrating tablet having suppressed bitterness of fast dissolving drug. The present in...
Invention 5'-position silyl ether derivative for nucleoside anti-cancer agent or anti-virus agent. [Problem...
Invention 5'-position dibenzyl monophosphate derivative of nucleoside-based anticancer agent or antivirus a...
Invention Dnmt inhibitor as solid tumor therapeutic drug. [Problem] To provide, in place of injected agent...
Invention Novel dnmt inhibitor as solid tumor therapeutic drug. [Problem] To provide, in place of injected ...
Invention Silyl etherified derivatives of 5-azacytidines in carbohydrate moiety. The present invention rela...
2017 Invention Tablet comprising an esomeprazole salt having improved chemical stability. The present invention ...
2016 Invention 5′-dibenzyl phosphates of 5-azacytidine or 2′-deoxy-5-azacytidine. The present invention relates ...
Invention Sugar moiety silyl ether derivative of 5-azacytidine. [Problem] To provide, as a substitute for a...
Invention 5'-position dibenzyl phosphoric acid ester of 5-azacytidine or 2'-deoxy body thereof. [Problem] T...
2015 Invention Film-coated tablets containing olmesartan medoxomil. Tablets containing olmesartan medoxomil are ...
2010 Invention Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredien...
2008 Invention Method for producing granulated matter. It has been demanded to provide a method for producing a ...
Invention Amorphous body composed of heterocyclic compound, solid dispersion and pharmaceutical preparation...
2003 Invention Heterocyclic compound and antitumor agent containing the same as active ingredient. The present i...